AcelRx Pharma Stock Analysis, Valuation (NASDAQ:ACRX)
Take a look at Amigobulls AcelRx Pharma stock analysis video. This video puts forward our latest analysis highlighting the pros and cons for ACRX stock.
Note: Amigobulls stock rating is our opinion based on the historical performance of the company's fundamentals. It is not indicative of the future performance of the stock.
AcelRx Pharmaceuticals Inc Stock Rating 1.6/5
We at Amigobulls use various financial measures including profit margins, revenue growth and dividends for ACRX stock analysis. We compare AcelRx Pharma valuation with its sector peers to gauge relative attractiveness of ACRX stock. AcelRx Pharma stock rating encapsulates our opinion about the company based on the fundamentals.
Should you buy ACRX stock?
- Long term revenue growth has been strong with a 5 year compounded annual growth of 11.7.
Should you sell ACRX stock?
- AcelRx Pharma sales declined by -89.1% year on year in 2018-03.
- AcelRx Pharma registered a negative operating margin of -666.73 (average) over the Trailing Twelve Months (TTM).
- Over the last 12 months, AcelRx Pharma had an average Net loss of -909.2%.
- PE ratio is meaningless for ACRX stock as the company has losses.
- The company is trading at a price to sales multiple of 60.7, which is higher in comparison to the Medical sector average of 6.5, making ACRX stock expensive.
- The company has a negative Return on Invested Capital of -639.4, which is a red flag.
- The company has a negative free cash flow margin of -2226.5.
Investors can use Amigobulls AcelRx Pharma stock analysis as a tool to arrive at accurate conclusions regarding financial health of the company and its valuation. Company's fundamentals remain one of the key driver of ACRX stock and helps investors in making good buy and sell decision.
AcelRx Pharma revenue growth is an indicator of the demand for a company's products while profit margin is indicative of company's pricing power and pricing strategy. One can also combine technical analysis and fundamental analysis to get a holistic picture about ACRX stock.